Comparing two prostate radiation schedules for intermediate risk
Part of Cancer clinical trials.
This trial compares giving radiation in 2 treatments versus 5 treatments for prostate cancer that hasn't spread. It's for men with low or intermediate risk prostate cancer who are healthy enough to undergo a short course of targeted radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your prostate cancer is low or intermediate risk (Gleason 7 or lower, PSA under 20).
- You have not had prostate surgery or radiation before.
- You are willing to get small markers placed in your prostate before radiation.
- You have no hip replacements or medical conditions that make radiation or MRI unsafe.
- If you have slightly higher risk features, you may take up to 6 months of hormone therapy as part of the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways of giving radiation to the prostate and pelvic lymph nodes. It also tests two different instructions for how full your bladder should be during treatment. The goal is to see which approach works better and is easier for patients.
This trial is testing a shorter course of radiation therapy (5 sessions instead of many) for men with prostate cancer that is at a higher risk but hasn't spread. The goal is to see if fewer, higher-dose treatments work as well while being more convenient.
This study compares two schedules of highly focused radiation (SBRT): 5 sessions to the prostate only, versus 5 sessions to the prostate and nearby pelvic lymph nodes. It aims to see which approach controls high-risk localized prostate cancer better while you also take hormone therapy.
This trial tests if a two-session radiation treatment works as well as a five-session one for men with low-risk or favorable intermediate-risk prostate cancer. It aims to reduce the number of visits while maintaining effectiveness.
This trial tests a type of radiation that adjusts to changes in your prostate during treatment. It aims to improve accuracy and reduce side effects for men with intermediate- or high-risk prostate cancer.
This trial is comparing two different MRI-guided radiation treatment plans to see which one better improves sexual quality of life in prostate cancer. It may help people decide between shorter or more treatment-session radiation approaches.
Hear when a new Prostate CA trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.